Takeda
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Takeda sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).
Takeda: 408 sponsored US clinical trials, 49 recruiting.
Takeda sponsors 408 registered US clinical trials on ClinicalTrials.gov, 49 of them currently recruiting, and 284 completed. 174 of these trials are in Phase 3-4 (later-stage) and 209 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Volunteers, with 16 trials.
Top-decile sponsor footprint
Takeda ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
284 of 340 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
408 total, page 8 of 9
Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
NCT00414102
Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy
NCT00760955
The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux
NCT00324974
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease
NCT00321984
Safety of Ramelteon in Elderly Subjects
NCT00568789
Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus
NCT00376181
Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
NCT00362115
Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis
NCT00321737
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
NCT00328627
Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease
NCT00316992
Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.
NCT00286468
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
NCT00312286
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
NCT00117884
Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease
NCT00325728
Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus
NCT00286442
Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
NCT00306384
Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia
NCT00286481
Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.
NCT00286429
Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
NCT00813527
Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes
NCT00286455
Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
NCT00286494
Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis
NCT00255151
Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn
NCT00255190
Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis
NCT00255164
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
NCT00251719
Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn
NCT00251745
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn
NCT00251758
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
NCT00251693
Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)
NCT00246909
Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia
NCT00263081
Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia
NCT00249899
Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia
NCT00249912
Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
NCT00251680
Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol
NCT00143663
Efficacy & Safety of Resatorvid in Adults With Severe Sepsis
NCT00143611
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
NCT00143676
Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
NCT00247390
Safety and Efficacy of Ramelteon in Healthy Subjects
NCT00671190
Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy
NCT00229437
Efficacy of Ramelteon in Adults With Chronic Insomnia
NCT00672724
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
NCT00487994
Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus
NCT00762736
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
NCT00672919
Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.
NCT00225264
Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease
NCT00672802
Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea
NCT00672061
Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus
NCT00225277
Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse
NCT00671632
Efficacy of Ramelteon in Subjects With Chronic Insomnia
NCT00671086
Study of Efficacy of Ramelteon in Adults With Chronic Insomnia
NCT00671125
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 119 |
| Phase 2 | 90 |
| Phase 3 | 148 |
| Phase 4 | 26 |
What is open in the Takeda pipeline
49 recruiting of 408 indexed (12% open); 284 completed (70%).
Phase mix: 174 late (III/IV) vs 209 early (I/II) (balanced across stages).
Top condition: Healthy Volunteers (16 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Takeda: open-pipeline peers nationwide
Peers matched on 408 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Takeda sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 408 trials (± recruiting share)
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Arcus Biosciences · 12% recruiting · 25 trials
- Ardelyx · 12% recruiting · 25 trials
- Kyowa Kirin Co. · 12% recruiting · 25 trials
- East Carolina University · 12% recruiting · 58 trials
Related
What to do with this Takeda page
408 registered trials is a research-attention snapshot, not an endorsement of Takeda or any single study.
- 49 of Takeda's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy Volunteers is the condition Takeda studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Volunteers trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Takeda pipeline card: 408 registered trials from official public datasets.Report a data error.